ANXA1 and melanoma: These data open a venue for investigations about the mechanisms of AnxA1 secreted by neutrophils, such as in the blood as in tumor metastasis and to propose AnxA1 blood levels or AnxA1+ neutrophils as a biomarker of early detection or melanoma progression.